Clinical Trial Update: Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating adding Triapine to cisplatin-based chemoradiation for advanced cervical and vaginal cancers is in active not recruiting status w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Adenocarcinoma
• Cervical Adenosquamous Carcinoma
• Cervical Cancer
• Cervical Squamous Cell Carcinoma
• Stage Ib2 Cervical Cancer
• Stage Iia Cervical Cancer
• Stage Iib Cervical Cancer
• Stage Iiib Cervical Cancer
• Stage Iva Cervical Cancer
• Stage Iva Vaginal Cancer
• Unresectable Vaginal Carcinoma
• Vaginal Adenocarcinoma
• Vaginal Adenosquamous Carcinoma
• Vaginal Cancer
• Vaginal Carcinoma
• Vaginal Squamous Cell Carcinoma
• Vaginal Squamous Cell Carcinoma Not Otherwise Specified

Drugs mentioned

• CISPLATIN (cisplatin)
• Triapine (Triapine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Vaginal Adenocarcinoma, Advanced Vaginal Adenosquamous Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-01-05